{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T16:02:31Z","timestamp":1743004951706,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":31,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071637739"},{"type":"electronic","value":"9781071637746"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3774-6_6","type":"book-chapter","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T10:02:25Z","timestamp":1709287345000},"page":"75-86","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mass Spectrometry-Based Metabolomics Multi-platform for Alzheimer\u2019s Disease Research"],"prefix":"10.1007","author":[{"given":"\u00c1lvaro","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Sayago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngeles","family":"Fern\u00e1ndez-Recamales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Gonz\u00e1lez-Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0188-4409(01)00316-2","volume":"32","author":"RB Maccioni","year":"2001","unstructured":"Maccioni RB, Mu\u00f1oz JP, Barbeito L (2001) The molecular bases of Alzheimer\u2019s disease and other neurodegenerative disorders. Arch Med Res 32:367\u2013381","journal-title":"Arch Med Res"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1039\/C3MT00301A","volume":"9","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2014) Characterization of metal profiles in serum during the progression of Alzheimer\u2019s disease. Metallomics 9:292\u2013300","journal-title":"Metallomics"},{"key":"6_CR3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O\u2019Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS\u2013ADRDA criteria. Lancet Neurol 6:734\u2013746","journal-title":"Lancet Neurol"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jchromb.2017.02.008","volume":"1071","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2017","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Sayago A, Fern\u00e1ndez-Recamales \u00c1 (2017) Metabolomics in Alzheimer\u2019s disease: the need of complementary analytical platforms for the identification of biomarkers to unravel the underlying pathology. J Chromatogr B Analyt Technol Biomed Life Sci 1071:75\u201392","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"6_CR5","first-page":"298","volume":"9","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2021","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Gonz\u00e1lez-Dom\u00ednguez \u00c1, Sayago A, Gonz\u00e1lez-Sanz JD, Lechuga-Sancho AM, Fern\u00e1ndez-Recamales \u00c1 (2021) Mechanistic insights into Alzheimer\u2019s disease unveiled through the investigation of disturbances in central metabolites and metabolic pathways. Biomedicine 9:298","journal-title":"Biomedicine"},{"key":"6_CR6","first-page":"52","volume":"8","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2018","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Sayago A, Fern\u00e1ndez-Recamales \u00c1 (2018) High-throughput direct mass spectrometry-based metabolomics to characterize metabolite fingerprints associated with Alzheimer\u2019s disease pathogenesis. Meta 8:52","journal-title":"Meta"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"13767","DOI":"10.1021\/acs.analchem.0c02008","volume":"92","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2020","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, J\u00e1uregui O, Queipo-Ortu\u00f1o MI, Andr\u00e9s-Lacueva C (2020) Characterization of the human exposome by a comprehensive and quantitative large-scale multianalyte metabolomics platform. Anal Chem 92:13767\u201313775","journal-title":"Anal Chem"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1039\/B906712B","volume":"40","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL (2011) Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 40:387\u2013426","journal-title":"Chem Soc Rev"},{"key":"6_CR9","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.2174\/1568026618666171211144918","volume":"17","author":"A Gonzalez-Dominguez","year":"2017","unstructured":"Gonzalez-Dominguez A, Duran-Guerrero E, Fernandez-Recamales A, Lechuga-Sancho AM, Sayago A, Schwarz M, Segundo C, Gonzalez-Dominguez R (2017) An overview on the importance of combining complementary analytical platforms in metabolomic research. Curr Top Med Chem 17:3289\u20133295","journal-title":"Curr Top Med Chem"},{"key":"6_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4155\/bio-2016-0202","volume":"9","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2017","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Sayago A, Fern\u00e1ndez-Recamales A (2017) Direct infusion mass spectrometry for metabolomic phenotyping of diseases. Bioanalysis 9:131\u2013148","journal-title":"Bioanalysis"},{"key":"6_CR11","series-title":"Methods in molecular biology","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-9236-2_3","volume-title":"High-throughput metabolomics","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2019","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Gonz\u00e1lez-Dom\u00ednguez \u00c1, Segundo C, Schwarz M, Sayago A, Mateos RM, Dur\u00e1n-Guerrero E, Lechuga-Sancho AM, Fern\u00e1ndez-Recamales \u00c1 (2019) High-throughput metabolomics based on direct mass spectrometry analysis in biomedical research. In: D\u2019Alessandro A (ed) High-throughput metabolomics, Methods in molecular biology, vol 1978. Humana, New York, pp 27\u201338"},{"key":"6_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jchromb.2008.04.033","volume":"871","author":"KK Pasikanti","year":"2008","unstructured":"Pasikanti KK, Ho PC, Chan EC (2008) Gas chromatography\/mass spectrometry in metabolic profiling of biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci 871:202\u2013211","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1039\/9781839163524-00219","volume-title":"Advanced mass spectrometry-based analytical separation techniques for probing the polar metabolome","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2021","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Gonz\u00e1lez-Dom\u00ednguez \u00c1, Sayago A, Fern\u00e1ndez-Recamales \u00c1 (2021) State-of-the-art mass spectrometry-based approaches to explore the polar metabolome: Alzheimer\u2019s disease as a case study. In: Ramautar R (ed) Advanced mass spectrometry-based analytical separation techniques for probing the polar metabolome. Royal Society of Chemistry, London, pp 219\u2013241"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1021\/cr300484s","volume":"113","author":"NL Kuehnbaum","year":"2013","unstructured":"Kuehnbaum NL, Britz-McKibbin P (2013) New advances in separation science for metabolomics: resolving chemical diversity in a post-genomic era. Chem Rev 113:2437\u20132468","journal-title":"Chem Rev"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4939-7704-8_8","volume-title":"Biomarkers for Alzheimer\u2019s disease drug development. Methods in molecular biology","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2018","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Gonz\u00e1lez-Dom\u00ednguez \u00c1, Sayago A, Fern\u00e1ndez-Recamales \u00c1 (2018) Mass spectrometry-based metabolomic multiplatform for Alzheimer\u2019s disease research. In: Perneczky R (ed) Biomarkers for Alzheimer\u2019s disease drug development. Methods in molecular biology, vol 1750. Humana Press, New York, pp 125\u2013137"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1007\/s00216-014-8102-3","volume":"406","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2014) Using direct infusion mass spectrometry for serum metabolomics in Alzheimer\u2019s disease. Anal Bioanal Chem 406:7137\u20137148","journal-title":"Anal Bioanal Chem"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1016\/j.bbadis.2014.09.014","volume":"1842","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2014) Region-specific metabolic alterations in the brain of the APP\/PS1 transgenic mice of Alzheimer\u2019s disease. Biochim Biophys Acta 1842:2395\u20132402","journal-title":"Biochim Biophys Acta"},{"key":"6_CR18","doi-asserted-by":"publisher","first-page":"13315","DOI":"10.1007\/s11356-014-2741-y","volume":"21","author":"A Gago-Tinoco","year":"2014","unstructured":"Gago-Tinoco A, Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Blasco-Moreno J, Bebianno MJ, G\u00f3mez-Ariza JL (2014) Metabolic signatures associated with environmental pollution by metals in Do\u00f1ana National Park using P. clarkii as bioindicator. Environ Sci Pollut Res Int 21:13315\u201313323","journal-title":"Environ Sci Pollut Res Int"},{"key":"6_CR19","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1002\/elps.201400544","volume":"36","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) High throughput multi-organ metabolomics in the APP\/PS1 mouse model of Alzheimer\u2019s disease. Electrophoresis 36:2237\u20132249","journal-title":"Electrophoresis"},{"key":"6_CR20","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1039\/b604498k","volume":"131","author":"T Sangster","year":"2006","unstructured":"Sangster T, Major H, Plumb R, Wilson AJ, Wilson ID (2006) A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. Analyst 131:1075\u20131078","journal-title":"Analyst"},{"key":"6_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","volume":"107","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2015) Metabolite profiling for the identification of altered metabolic pathways in Alzheimer\u2019s disease. J Pharm Biomed Anal 107:75\u201381","journal-title":"J Pharm Biomed Anal"},{"key":"6_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","volume":"102","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer\u2019s disease by direct infusion mass spectrometry. J Pharm Biomed Anal 102:425\u2013435","journal-title":"J Pharm Biomed Anal"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.talanta.2014.07.075","volume":"131","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2015) Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer\u2019s disease. Talanta 131:480\u2013489","journal-title":"Talanta"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jpba.2015.01.025","volume":"107","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP\/PS1 transgenic model of Alzheimer\u2019s disease. J Pharm Biomed Anal 107:378\u2013385","journal-title":"J Pharm Biomed Anal"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biochi.2015.01.005","volume":"110","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Deciphering metabolic abnormalities associated with Alzheimer\u2019s disease in the APP\/PS1 mouse model using integrated metabolomic approaches. Biochimie 110:119\u2013128","journal-title":"Biochimie"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1039\/C4MB00747F","volume":"11","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Metabolomic investigation of systemic manifestations associated with Alzheimer\u2019s disease in the APP\/PS1 transgenic mouse model. Mol BioSyst 11:2429\u20132440","journal-title":"Mol BioSyst"},{"key":"6_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/elps.201400450","volume":"36","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Metabolomics reveals significant impairments in the immune system of the APP\/PS1 transgenic mice of Alzheimer\u2019s disease. Electrophoresis 36:577\u2013587","journal-title":"Electrophoresis"},{"key":"6_CR28","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1002\/elps.201400196","volume":"35","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda A, Garc\u00eda-Barrera T, Barbas C, G\u00f3mez-Ariza JL (2014) Metabolomic profiling of serum in the progression of Alzheimer\u2019s disease by capillary electrophoresis-mass spectrometry. Electrophoresis 35:3321\u20133330","journal-title":"Electrophoresis"},{"key":"6_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2174\/1567205013666160129095138","volume":"13","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2016","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Rup\u00e9rez FJ, Garc\u00eda-Barrera T, Barbas C, G\u00f3mez-Ariza JL (2016) Metabolomic-driven elucidation of pathological mechanisms associated with Alzheimer\u2019s disease and mild cognitive impairment. Curr Alzheimer Res 13:641\u2013653","journal-title":"Curr Alzheimer Res"},{"key":"6_CR30","first-page":"229","volume":"10","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2020","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Gonz\u00e1lez-Dom\u00ednguez \u00c1, Sayago A, Fern\u00e1ndez-Recamales \u00c1 (2020) Recommendations and best practices for standardizing the pre-analytical processing of blood and urine samples in metabolomics. Meta 10:229","journal-title":"Meta"},{"key":"6_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ab.2014.07.016","volume":"465","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Castilla-Quintero R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2014) Development of a metabolomic approach based on urine samples and direct infusion mass spectrometry. Anal Biochem 465:20\u201327","journal-title":"Anal Biochem"}],"container-title":["Methods in Molecular Biology","Biomarkers for Alzheimer\u2019s Disease Drug Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3774-6_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T12:02:24Z","timestamp":1716465744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3774-6_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9781071637739","9781071637746"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3774-6_6","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"2 March 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}